Semorinemab
Product Specifications
CAS Number
2159141-27-0
Target
Microtubule Associated
Related Pathways
Cytoskeletal Signaling
Purity
0.972
Bioactivity
Semorinemab (RG6100) is a humanised monoclonal antibody targeting the N-terminal domain of tau protein with a Kd of 3.8 nM, suitable for Alzheimer's disease research. It binds all six human tau isoforms and reduces tau accumulation.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP9C759-01 1 mg
Recombinant Swine C-C Motif Chemokine (CCL2), N-His-GST
Sign In for Pricing
View Details AP9C759-02 10 µg
Recombinant Swine C-C Motif Chemokine (CCL2), N-His-GST
Sign In for Pricing
View Details AP9C759-03 200 µg
Recombinant Swine C-C Motif Chemokine (CCL2), N-His-GST
Sign In for Pricing
View Details AP9C759-04 5 mg
Recombinant Swine C-C Motif Chemokine (CCL2), N-His-GST
Sign In for Pricing
View Details AP9C759-05 50 µg
Recombinant Swine C-C Motif Chemokine (CCL2), N-His-GST
Sign In for Pricing
View Details 